Behavioral intervention consisted of counseling by a dietitian or similarly qualified healthcare professional every 4 weeks via in-person visits or telephone on adherence to a reduced-calorie diet (500 kcal deficit a day relative to the energy expenditure estimated at randomization) and increased physical activity (150 minutes a week encouraged, for example, walking), both recorded daily (via a diary, app or other tools, which were reviewed during counseling sessions)
For example, one small-scale Ozempic does not have Food and Drug Administration (FDA)-approval for alcohol use disorder
The injection itself follows standard subcutaneous technique
Key Points Tirzepatide (Mounjaro/Zepbound) works differently than semaglutide (Ozempic/Wegovy) by targeting two hormones instead of one Studies show tirzepatide typically leads to greater weight loss (15-20% vs 8-10%) and better blood sugar control than semaglutide Switching is generally straightforward you can finish your semaglutide dose and start tirzepatide about a week later on your normal dose day Most people start at a lower tirzepatide dose (2.5mg or 5mg) even if they were on a high dose of semaglutide Thinking about making the switch from semaglutide (Ozempic or Wegovy) to tirzepatide (Mounjaro or Zepbound)
A more accurate frame is: berberine is a metabolic-support supplement that may help some people a little, especially if blood sugar/insulin resistance is part of the picture
